Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FB3KN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,943
Award facts
- Contract value 100% obligated
- $6,943.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $6,943.10 by the Defense Logistics Agency for the supply of Nexplanon 68 mg implants. The contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a discrete purchase order under DMS Pharmaceutical Group's larger indefinite delivery contract with the Defense Logistics Agency. No set-aside designation was applied to this award, allowing the contractor to compete on an unrestricted basis despite its small business status. The performance location is Park Ridge, Illinois, where the vendor maintains its operations as a primary pharmaceutical distributor to federal healthcare systems.
This delivery order exemplifies the operational scope of DMS Pharmaceutical Group's relationship with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 indefinite delivery contract vehicle active through November 2026. The contract portfolio encompasses prescription medications, biologics, medical consumables, and specialty pharmaceutical products serving Department of Defense healthcare facilities worldwide. Nexplanon implants, a subdermal contraceptive device, fall within the broader category of pharmaceutical products the contractor supplies to military health systems. Through this established IDC framework, the Defense Logistics Agency maintains efficient access to a comprehensive range of pharmaceutical inventory while leveraging DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FB3KN?
SPE2DB25FB3KN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FB3KN worth?
The government has obligated $6,943 on SPE2DB25FB3KN.
Is contract SPE2DB25FB3KN an order under another contract?
Yes. SPE2DB25FB3KN is a delivery order under SPE2DB20D9761, an indefinite delivery contract.
Was contract SPE2DB25FB3KN competed?
The extent of competition for SPE2DB25FB3KN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award